ILM1 Stock Overview
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medios AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €14.12 |
| 52 Week High | €19.76 |
| 52 Week Low | €13.34 |
| Beta | 1.07 |
| 1 Month Change | -19.50% |
| 3 Month Change | -2.62% |
| 1 Year Change | -27.37% |
| 3 Year Change | -60.78% |
| 5 Year Change | -19.08% |
| Change since IPO | 81.05% |
Recent News & Updates
Recent updates
Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly
Aug 19
Is Medios AG (ETR:ILM1) Trading At A 39% Discount?
Mar 02Is Medios (ETR:ILM1) Using Too Much Debt?
Nov 27Is It Too Late To Consider Buying Medios AG (ETR:ILM1)?
Oct 21Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly
Aug 12Is Now The Time To Look At Buying Medios AG (ETR:ILM1)?
Jul 07Is Medios (ETR:ILM1) Using Too Much Debt?
Apr 28Here's Why I Think Medios (ETR:ILM1) Is An Interesting Stock
Mar 07What Does Medios AG's (ETR:ILM1) Share Price Indicate?
Feb 08Medios (ETR:ILM1) Has A Pretty Healthy Balance Sheet
Nov 29Is There Now An Opportunity In Medios AG (ETR:ILM1)?
Oct 02Medios AG's (ETR:ILM1) Intrinsic Value Is Potentially 35% Above Its Share Price
Jun 18What Is Medios AG's (ETR:ILM1) Share Price Doing?
May 25Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts
Jan 21What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition
Jan 19Is It Time To Consider Buying Medios AG (ETR:ILM1)?
Dec 24Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week
Dec 09The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It
Dec 08Medios AG's (ETR:ILM1) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 22What Can We Make Of Medios AG’s (ETR:ILM1) High Return On Capital?
Jun 22Shareholder Returns
| ILM1 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -5.1% | 4.1% | -1.5% |
| 1Y | -27.4% | -0.8% | 0.9% |
Return vs Industry: ILM1 underperformed the German Healthcare industry which returned -3.8% over the past year.
Return vs Market: ILM1 underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| ILM1 volatility | |
|---|---|
| ILM1 Average Weekly Movement | 8.8% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ILM1 has not had significant price volatility in the past 3 months.
Volatility Over Time: ILM1's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 424 | Matthias Gaertner | www.medios.ag |
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.
Medios AG Fundamentals Summary
| ILM1 fundamental statistics | |
|---|---|
| Market cap | €336.14m |
| Earnings (TTM) | €18.81m |
| Revenue (TTM) | €1.78b |
17.9x
P/E Ratio0.2x
P/S RatioIs ILM1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ILM1 income statement (TTM) | |
|---|---|
| Revenue | €1.78b |
| Cost of Revenue | €1.68b |
| Gross Profit | €108.63m |
| Other Expenses | €89.82m |
| Earnings | €18.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 0.79 |
| Gross Margin | 6.09% |
| Net Profit Margin | 1.05% |
| Debt/Equity Ratio | 0% |
How did ILM1 perform over the long term?
See historical performance and comparison